Condition
Uterine Adenomyosis
Total Trials
5
Recruiting
0
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
60%
3 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (1)
Early P 1 (1)
P 3 (2)
P 4 (1)
Trial Status
Completed2
Unknown1
Not Yet Recruiting1
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06652945Not ApplicableNot Yet RecruitingPrimary
Efficacy of Uterine Artery Embolization (UAE) in Management of Symptomatic Uterine Adenomyosis
NCT03421639Phase 4Active Not RecruitingPrimary
Aromatase Plus GnRH Analogue Versus GnRH Analog Alone in Adenomyosis
NCT03927651Early Phase 1Completed
ICG to Assess Ovarian Perfusion
NCT01483417Phase 3Unknown
Single Incision Laparoscopic Surgery (SILS) Versus Conventional Laparoscopic Hysterectomy
NCT01064128Phase 3Completed
Study of Different Pain Scores in Single-Port Access (SPA) Laparoscopic Hysterectomy Versus Conventional Laparoscopic Hysterectomy
Showing all 5 trials